Symbicort

Special precautions for disposal and other handling

Marketing authorisation holder

Marketing authorisation number(s)

Date of first authorisation/renewal of the authorisation

Date of revision of the text

Components:

Formoterol, Budesonide

Method of action:

Anti-Inflammatory, Beta2-Adrenomimetic, Bronchodilator, Drugs For Obstructive Airway Diseases, Glucocorticoid, Immunosuppressive, Antiallergic, Anti-Asthmatic

Treatment option:

Asthma, Chronic Obstructive Lung Disease

Medically reviewed by Oliinyk Elizabeth Ivanovna, PharmD. Last updated on 26.06.2023

Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!

Special precautions for disposal and other handling

Dispose of the medication in accordance with local regulations for medical waste.

Marketing authorisation holder

AstraZeneca UK Limited,

600 Capability Green,

Luton, LU1 3LU, UK.

Marketing authorisation number(s)

PL 17901/0092

Date of first authorisation/renewal of the authorisation

Date of first authorisation: 15^th May 2001

Date of last renewal: 19^th February 2010

Date of revision of the text

27^th April 2018

A-Z index:

A B C D E F G H I J K L M N O P Q R S T U V Y Z